Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma
/in Hyperthermia, International Publications, Malignant Pleural Mesothelioma /von 2006-11-01 / Int J Hyperthermia 2006 Nov;22(7):613-21[Effects of pirarubicin chemotherapy combined with hyperthermia on gastric cancer in vitro]
/in Gastric Cancer, Hyperthermia, International Publications /von 2006-10-01 / Nan Fang Yi Ke Da Xue Xue Bao 2006 Oct;26(10):1487-90[Clinical impact of locoregional hyperthermia in gynecological oncology]
/in Breast Cancer, Cervical Cancer, Hyperthermia, International Publications /von 2006-10-01 / Zentralbl Gynakol 2006 Oct;128(5):255-60Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2006-09-15 / Cancer 2006 Sep;107(6):1373-82The role of hyperthermia in combined treatment in the management of soft tissue sarcoma
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2006-07-01 / Curr Oncol Rep 2006 Jul;8(4):305-9[Therapeutic effect of whole body hyperthermia combined with chemotherapy in patients with advanced cancer]
/in Gastric Cancer, Hyperthermia, International Publications, NSCLC /von 2006-06-01 / Zhong Nan Da Xue Xue Bao Yi Xue Ban 2006 Jun;31(3):350-2Analysis of cell proliferation and cell death during in situ hyperthermic treatment of neoplastic cells: a case report of human non-Hodgkin lymphoma
/in Hyperthermia, International Publications, Malignant Lymphoma /von 2006-05-24 / Biomed. Pharmacother. 2006 Jun;60(5):227-32High-risk soft tissue sarcoma: clinical trial and hyperthermia combined chemotherapy
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2006-05-01 / Int J Hyperthermia 2006 May;22(3):235-9Hyperthermia today: electric energy, a new opportunity in cancer treatment
/in Hyperthermia, International Publications /von 2006-04-01 / J Cancer Res Ther 2006 Apr-Jun;2(2):41-6
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution